Literature DB >> 3353509

Further studies on the radiation-induced expression of a tumor-specific antigen in human cell hybrids.

C Sun1, J L Redpath, M Colman, E J Stanbridge.   

Abstract

The neoplastic transformation of human cell hybrids (HeLa x skin fibroblasts) is accompanied by the expression of a cell surface protein for which monoclonal antibodies have been raised. The gamma-radiation-induced neoplastic transformation of these cells has been studied where the expression of this cell surface protein, as detected by immunoperoxidase staining, has been used as an end point. The yield of foci of positively staining cells has been shown to increase with increasing time postirradiation at which the assay is done and decrease with increasing density of viable cells plated postirradiation. The time of plating postirradiation is also an important parameter with transformation frequencies increasing over the first 6 h of postirradiation holding at confluence, followed by a gradual decrease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3353509

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  4 in total

1.  Re-evaluation of the RBE of 29 kV x-rays (mammography x-rays) relative to 220 kV x-rays using neoplastic transformation of human CGL1-hybrid cells.

Authors:  W Göggelmann; C Jacobsen; W Panzer; L Walsh; H Roos; E Schmid
Journal:  Radiat Environ Biophys       Date:  2003-10-09       Impact factor: 1.925

2.  Nonlinear response for neoplastic transformation following low doses of low let radiation.

Authors:  J Leslie Redpath
Journal:  Nonlinearity Biol Toxicol Med       Date:  2005-01

3.  Identification of the HeLa tumor-associated antigen, p75/150, as intestinal alkaline phosphatase and evidence for its transcriptional regulation.

Authors:  K M Latham; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Isolation of human cell hybrids (HeLa x skin fibroblast) expressing a radiation-induced tumour-associated antigen.

Authors:  M S Mendonca; J L Redpath
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.